✦ LIBER ✦

Natural prevalence of hepatitis C virus (HCV) variants resistant to protease and polymerase inhibitors in patients infected with HCV genotype 1 in Tunisia

✍ Scribed by Aissa Larousse, Jameleddine; Trimoulet, Pascale; Recordon-Pinson, Patricia; Papuchon, Jennnifer; Azzouz, Mohamed Mssadak; Ben Mami, Nabyl; Cheikh, Imed; Triki, Henda; Fleury, Hervé

Book ID: 121749299
Publisher: John Wiley and Sons
Year: 2014
Tongue: English
Weight: 290 KB
Volume: 86
Category: Article
ISSN: 0146-6615
DOI: 10.1002/jmv.23958

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Naturally occurring hepatitis C virus (H

Naturally occurring hepatitis C virus (HCV) NS3/4A protease inhibitor resistance-related mutations in HCV genotype 1-infected subjects in Italy

✍ Vicenti, I.; Rosi, A.; Saladini, F.; Meini, G.; Pippi, F.; Rossetti, B.; Sidella 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 171 KB

PVI-14 NS3 protease polymorphism and res

PVI-14 NS3 protease polymorphism and resistance profile to protease inhibitors in French patients infected with hepatitis C virus (HCV) genotypes 1 to 5

✍ S. Vallet; F. Viron; H. Le Guillou-Guillemette; C. Henquell; P. Trimoulet; F. Ab 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Hepatitis C virus (HCV) genotypes in Spa

Hepatitis C virus (HCV) genotypes in Spanish patients with HCV infection: relationship between HCV genotype 1b, cirrhosis and hepatocellular carcinoma

✍ Francesc X. López-Labrador; Sergi Ampurdanés; Xavier Forns; Antoni Castells; Jua 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 922 KB

Characterization of vaniprevir, a hepati

Characterization of vaniprevir, a hepatitis C virus NS3/4A protease inhibitor, in patients with HCV genotype 1 infection: Safety, antiviral activity, resistance, and pharmacokinetics

✍ Lawitz, Eric; Sulkowski, Mark; Jacobson, Ira; Kraft, Walter K.; Maliakkal, Bened 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 367 KB

Prevalence of antibody to hepatitis C vi

Prevalence of antibody to hepatitis C virus (HCV) in HIV-1-infected patients (nice seroco cohort)

✍ J. F. Quaranta; S. R. Delaney; S. Alleman; J. P. Cassuto; P. Dellamonica; J. P. 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB 👁 2 views

## Abstract The prevalence of antibody to hepatitis C virus (HCV) in a cohort of 272 HIV‐infected patients was assessed by means of 4 anti‐HCV assays: a 1st generation and a neutralization test, a 2nd generation test, and a confirmatory test, the dot‐blot Matrix HCV™ immunoassay. The cohort include

Prevalence of hepatitis C virus variants

Prevalence of hepatitis C virus variants resistant to NS3 protease inhibitors or the NS5A inhibitor (BMS-790052) in hepatitis patients with genotype 1b

✍ Fumitaka Suzuki; Hitomi Sezaki; Norio Akuta; Yoshiyuki Suzuki; Yuya Seko; Yusuke 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 156 KB